These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 22939244)
1. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ko MA; Zehong G; Virtanen C; Guindi M; Waddell TK; Keshavjee S; Darling GE Ann Thorac Surg; 2012 Oct; 94(4):1094-102; discussion 1102-3. PubMed ID: 22939244 [TBL] [Abstract][Full Text] [Related]
2. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy. Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082 [TBL] [Abstract][Full Text] [Related]
3. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery. Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576 [TBL] [Abstract][Full Text] [Related]
4. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Hummel R; Wang T; Watson DI; Michael MZ; Van der Hoek M; Haier J; Hussey DJ Oncol Rep; 2011 Oct; 26(4):1011-7. PubMed ID: 21743970 [TBL] [Abstract][Full Text] [Related]
5. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808 [TBL] [Abstract][Full Text] [Related]
6. Can miRNA profiling allow us to determine which patients with esophageal cancer will respond to chemoradiotherapy? Mayne GC; Hussey DJ; Watson DI Expert Rev Anticancer Ther; 2013 Mar; 13(3):271-3. PubMed ID: 23477513 [TBL] [Abstract][Full Text] [Related]
7. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
8. [Differential expression of hsa-miR-126 and hsa-miR-518b in esophageal squamous carcinoma]. Cai H; Wang JS; Zhang MX; Duan XY; Ma RQ Nan Fang Yi Ke Da Xue Xue Bao; 2011 Jan; 31(1):23-7. PubMed ID: 21269950 [TBL] [Abstract][Full Text] [Related]
9. A specific miRNA signature correlates with complete pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Della Vittoria Scarpati G; Falcetta F; Carlomagno C; Ubezio P; Marchini S; De Stefano A; Singh VK; D'Incalci M; De Placido S; Pepe S Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1113-9. PubMed ID: 22172905 [TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis. Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173 [TBL] [Abstract][Full Text] [Related]
11. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Hong L; Han Y; Zhang H; Li M; Gong T; Sun L; Wu K; Zhao Q; Fan D Ann Surg; 2010 Jun; 251(6):1056-63. PubMed ID: 20485139 [TBL] [Abstract][Full Text] [Related]
12. Low expression of Bax predicts poor prognosis in patients with locally advanced esophageal cancer treated with definitive chemoradiotherapy. Kang SY; Han JH; Lee KJ; Choi JH; Park JI; Kim HI; Lee HW; Jang JH; Park JS; Kim HC; Kang S; Oh YT; Chun M; Kim JH; Sheen SS; Lim HY Clin Cancer Res; 2007 Jul; 13(14):4146-53. PubMed ID: 17634542 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma. Izquierdo L; Ingelmo-Torres M; Mallofré C; Lozano JJ; Verhasselt-Crinquette M; Leroy X; Colin P; Comperat E; Roupret M; Alcaraz A; Mengual L BJU Int; 2014 May; 113(5):813-21. PubMed ID: 24180461 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Odenthal M; Bollschweiler E; Grimminger PP; Schröder W; Brabender J; Drebber U; Hölscher AH; Metzger R; Vallböhmer D Int J Cancer; 2013 Nov; 133(10):2454-63. PubMed ID: 23649428 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Isozaki Y; Hoshino I; Nohata N; Kinoshita T; Akutsu Y; Hanari N; Mori M; Yoneyama Y; Akanuma N; Takeshita N; Maruyama T; Seki N; Nishino N; Yoshida M; Matsubara H Int J Oncol; 2012 Sep; 41(3):985-94. PubMed ID: 22752059 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of microRNA expression profiles that may predict recurrence of localized stage I non-small cell lung cancer after surgical resection. Patnaik SK; Kannisto E; Knudsen S; Yendamuri S Cancer Res; 2010 Jan; 70(1):36-45. PubMed ID: 20028859 [TBL] [Abstract][Full Text] [Related]
17. Serum microRNA profiles as prognostic/predictive markers in the multimodality therapy of locally advanced adenocarcinomas of the gastroesophageal junction. Odenthal M; Hee J; Gockel I; Sisic L; Schmitz J; Stoecklein NH; Driemel C; Möhlendick B; Schmidt T; Knoefel WT; Lang H; Büttner R; Ott K; Vallböhmer D Int J Cancer; 2015 Jul; 137(1):230-7. PubMed ID: 25429911 [TBL] [Abstract][Full Text] [Related]
18. [Expression profiles of microRNAs in radioresistant esophageal cell line]. Zheng ZF; Su HF; Zou Y; Peng Z; Wu SX Zhonghua Yi Xue Za Zhi; 2011 Mar; 91(9):639-42. PubMed ID: 21600139 [TBL] [Abstract][Full Text] [Related]
19. Microarray analysis of microRNA expression in cutaneous squamous cell carcinoma. Sand M; Skrygan M; Georgas D; Sand D; Hahn SA; Gambichler T; Altmeyer P; Bechara FG J Dermatol Sci; 2012 Dec; 68(3):119-26. PubMed ID: 23026055 [TBL] [Abstract][Full Text] [Related]
20. Identification of microRNA Biomarkers of Response to Neoadjuvant Chemoradiotherapy in Esophageal Adenocarcinoma Using Next Generation Sequencing. Chiam K; Mayne GC; Watson DI; Woodman RJ; Bright TF; Michael MZ; Karapetis CS; Irvine T; Phillips WA; Hummel R; Wang T; Pimlott LK; Marri S; Astill DS; Ruszkiewicz AR; Thompson SK; Hussey DJ Ann Surg Oncol; 2018 Sep; 25(9):2731-2738. PubMed ID: 29987600 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]